Entry |
|
Name |
Dyphylline;
Diprophylline
|
Formula |
C10H14N4O4
|
Exact mass |
254.1015
|
Mol weight |
254.2426
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DA Xanthines
R03DA01 Diprophylline
D00691 Dyphylline (USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
211 Cardiotonics
2115 Caffeines
D00691 Dyphylline (USP); Diprophylline (JAN/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for respiratory organs
26 Antitussives and expectorants
D00691 Dyphylline (USP)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Diprophylline
D00691 Dyphylline (USP)
Drug groups [BR:br08330]
Respiratory system agent
DG01616 Xanthine derivative
DG01609 Xanthine-type bronchodilator
D00691 Dyphylline
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA1
D00691 Dyphylline (USP) <JP>
ADORA2B
D00691 Dyphylline (USP) <JP>
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE
D00691 Dyphylline (USP) <JP>
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 18
1 C8y C 28.8427 -14.7000
2 C8y C 28.8427 -16.0934
3 N4y N 30.1664 -14.2820
4 C8y C 27.6584 -14.0034
5 N4y N 27.6584 -16.7900
6 N5x N 30.1664 -16.5810
7 C1b C 31.3507 -13.5854
8 C8x C 31.0024 -15.4664
9 N4y N 26.4044 -14.7000
10 O5x O 27.6584 -12.6100
11 C8y C 26.4044 -16.0934
12 C1a C 27.6584 -18.2530
13 C1c C 32.5351 -14.2820
14 C1a C 25.2201 -14.0034
15 O5x O 25.2201 -16.7900
16 C1b C 33.7891 -13.5854
17 O1a O 32.5351 -15.6754
18 O1a O 34.9734 -14.2820
BOND 19
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 1
9 4 10 2
10 5 11 1
11 5 12 1
12 7 13 1
13 9 14 1
14 11 15 2
15 13 16 1
16 13 17 1
17 16 18 1
18 6 8 2
19 9 11 1
|